Carlisle Interconnect Technologies News/PR

CIT Expands Medical and Test & Measurement Capabilities with Acquisition of MicroConnex

ST. AUGUSTINE, FLORIDA, May 24, 2019 – Carlisle Interconnect Technologies (CIT), is pleased to announce the acquisition of MicroConnex Corporation, a privately held manufacturer of highly engineered microminiature flex circuits for the Medical and Test & Measurement markets. MicroConnex will operate under CIT’s Medical Technologies Business Unit known as Carlisle Medical Technologies (CMT), a leader in the medical device cable and interconnect market.

This acquisition aligns with CMT’s focus on expanding its platform of advanced technology capabilities to further enable highly-integrated devices that support critical and cost-effective performance requirements.

“With this acquisition, we are steps closer to fulfilling CMT’s vision to be the industry leader in the design, development and vertically-integrated manufacturing of advanced medical device solutions,” Constantine Davlantes, VP and GM of Carlisle Medical Technologies. “Not only is CMT a leader in providing innovative solutions, but we’re backed by world-class quality and customer support.”

MicroConnex brings deep technical expertise and process capabilities for developing custom precision flex circuits and hybrid electronics for medical catheters, ultrasound transducers, semiconductor tests and other applications requiring space-optimizing configurations with stringent tolerance requirements. MicroConnex’s highly specialized manufacturing processes include thin-film sputtering, laser ablation and precision laser micromachining.

“Our team is excited to partner with CIT to continue our focus on advanced technologies,” said Paul Henwood, president and CEO of MicroConnex. “The combination of MicroConnex and CIT will open new doors for MicroConnex to drive growth, innovation and cutting-edge product solutions within the Medical and Test & Measurement markets. CIT is a great cultural fit with MicroConnex and we are excited to begin the next chapter in our company’s history.”

MicroConnex builds on CIT’s recent acquisition of redgroup, a company specializing in design and development of complex catheter technologies. Both acquisitions broaden Carlisle IT’s expertise and the value the company delivers to OEM customers.

MicroConnex Logo

Member of
©2024 Amphenol CIT. All Rights Reserved.
All trademarks, service marks and trade names are property of their respective holding companies.
Amphenol CIT products are subject to U.S. export control regulations.
They may be subject to certain licensing requirements and restricted for export.